Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02806765

Effect of Dietary Supplementation on Dynamic Stability

Effects of a Single Nutrient Supplementation on Dynamic Stability in Community Dwelling Older Adults

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Arizona State University · Academic / Other
Sex
All
Age
65 Years – 95 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether specific nutrient supplementation can improve dynamic stability in older adults.

Detailed description

The primary objective of this study is to evaluate the effect of a single nutrient dietary supplement on dynamic stability in an older population. Dynamic stability, or walking stability, will be assessed with accelerometers while subjects are walking on a flat surface for about 60 seconds. Dynamic stability will be defined by the maximum Lyapunov exponent (maxLE), Floquet multiplier, or motor control timing, change from baseline. Postural stability will also be measured in a still and standing subject, with foot placement standardized on a force plate, and with the subject looking in the forward direction with arms by their sides. Two visual conditions will be given: eyes-open (EO) and eyes-closed (EC). Each measurement will last for 60 seconds and will be repeated twice for each condition. A three-minute rest will be provided between measurements.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol25 micrograms of (1S,3Z)-3-\[(2E)-2-\[(1R,3aS,7aR)-7a-methyl-1-\[(2R)-6-methylheptan-2-yl\]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene\]ethylidene\]-4-methylidenecyclohexan-1-ol every day for 6 months
OTHERControlPlacebo in Softgel form

Timeline

Start date
2016-09-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-06-21
Last updated
2023-02-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02806765. Inclusion in this directory is not an endorsement.